ANTICORPS CIBLANT IL-13RA2 ET SON APPLICATION
- 专利权人:
- Ltd.;Carsgen Therapeutics Co.
- 发明人:
- 申请号：
- EP18753921.8
- 公开号：
- EP3594241A1
- 申请日:
- 2018.02.08
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided is an antibody that specifically recognizes IL-13RA2, which can be used in the manufacture of a targeting anti-tumor medicament as well as a medicament for diagnosing a tumor.
- 来源网站：
- 中国工程科技知识中心
